- Home
- BZ vs BBIO Comparison
BZ vs BBIO Comparison
Compare BZ & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZ
- BBIO
- Stock Information
- Founded
- BZ 2013
- BBIO 2015
- Country
- BZ China
- BBIO United States
- Employees
- BZ N/A
- BBIO N/A
- Industry
- BZ Computer Software: Programming Data Processing
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- BZ Technology
- BBIO Health Care
- Exchange
- BZ Nasdaq
- BBIO Nasdaq
- Market Cap
- BZ 11.3B
- BBIO 9.4B
- IPO Year
- BZ 2021
- BBIO 2019
- Fundamental
- Price
- BZ $24.24
- BBIO $53.89
- Analyst Decision
- BZ Strong Buy
- BBIO Strong Buy
- Analyst Count
- BZ 5
- BBIO 16
- Target Price
- BZ $21.20
- BBIO $64.44
- AVG Volume (30 Days)
- BZ 3.9M
- BBIO 2.0M
- Earning Date
- BZ 08-20-2025
- BBIO 11-11-2025
- Dividend Yield
- BZ 0.69%
- BBIO N/A
- EPS Growth
- BZ 51.73
- BBIO N/A
- EPS
- BZ 0.66
- BBIO N/A
- Revenue
- BZ $1,083,348,363.00
- BBIO $235,812,000.00
- Revenue This Year
- BZ $15.46
- BBIO $115.97
- Revenue Next Year
- BZ $13.10
- BBIO $65.50
- P/E Ratio
- BZ $36.59
- BBIO N/A
- Revenue Growth
- BZ 14.01
- BBIO 7.62
- 52 Week Low
- BZ $12.17
- BBIO $21.72
- 52 Week High
- BZ $25.26
- BBIO $55.13
- Technical
- Relative Strength Index (RSI)
- BZ 60.58
- BBIO 60.09
- Support Level
- BZ $22.85
- BBIO $51.85
- Resistance Level
- BZ $23.64
- BBIO $53.81
- Average True Range (ATR)
- BZ 0.62
- BBIO 1.69
- MACD
- BZ -0.07
- BBIO 0.16
- Stochastic Oscillator
- BZ 71.71
- BBIO 83.78
About BZ KANZHUN LIMITED American Depository Shares
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.